Original language | English |
---|---|
Pages (from-to) | 425-426 |
Number of pages | 2 |
Journal | Clinical Cancer Research |
Volume | 28 |
Issue number | 2 |
DOIs |
|
Publication status | Published - 15 Jan 2022 |
Bibliographical note
Funding Information:S.I. Buschow reports other support from ISA pharmaceuticals b.v. outside the submitted work. M.P. Peppelenbosch reports grants, personal fees, and non-financial support from Pfizer; grants and personal fees from ZONMW/NWO; and grants from KWF during the conduct of the study; grants from MLDS, CSC, and Wavax; personal fees from NCS, CSF, SNSF, ESF, and Dialecta; grants and personal fees from FWO and European Commission outside the submitted work. M.J. Bruno reports grants and other support from Boston Scientific, Cook Medical, Pentax Medical; grants from Mylan, ChiRoStim, and 3M outside the submitted work. No disclosures were reported by the other authors.